Global Trimethylglycine
Global Trimethylglycine

Trimethylglycine Comprehensive Study by Type (Biosynthesis, Chemical Synthesis, PCR technique), Application (Dietary Supplement, Agriculture and Aquaculture, Clinical trials, Cosmetics, Detergents), Availabilty (Liquid, Powder, Capsules), End User (Pharmaceutical and Neutraceuticals, Fertilizer Companies, Chemical industries) Players and Region - Global Market Outlook to 2024

Trimethylglycine Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Feb 2020 Edition 225 Pages 223 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Trimethylglycine (TMG) is refer as a substance which is produced in the body commonly called betaine. It helps break down another naturally occurring substance called homocysteine Betaine is seen in following microorganisms, plants, and animals and is a significant component of many foods including wheat, shellfish, spinach, and sugar beets. Betaine/ trimethylglycine is a zwitterionic quaternary ammonium compound, also known as glycine betaine, lycine, and oxyneurine. Trimethylglycine (TMG) is a derivative of the amino acid glycine and has been posited to reduce lactic acid, enhance oxygen use, and reduce seizure activity during times of stress. It was first betaine discovered in sugar beets.This growth is primarily driven by Highly Demanded As Supplement and Growing Use For Treatment Of Depression, Schizophrenia, Demyelination Diseases, Liver Disease, Dementia, Arthritis, And Other Conditions.

Globally, a noticeable market trend is evident Growing Demand Of TMG Containing Fertilizer. Major Vendors, such as American Crystal Sugar (United States), Associated British Foods (United Kingdom), BASF (Germany), DuPont (United States), Cambridge Isotope Laboratories (United States), Compound Solutions (United States), Creative Compounds (United States), Nutreco N.V. (Netherlands), Amino GMBH (Germany) and Kao Corporation (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In June 2019 ABF announces joint venture with Wilmar International. Associated British Foods plc and Yihai Kerry Arawana Holdings Co Ltd, a subsidiary of Wilmar International Limited, have executed a binding term sheet setting out their intention to form a 50:50 joint venture in China for the manufacture, sale, and distribution of yeast and bakery ingredients. The joint venture will acquire existing Chinese yeast and bakery ingredients activities of AB Mauri, a division of ABF, and will leverage Yihai Kerry Arawana’s supply chain, extensive sales and distribution network and local market expertise in China.
On 5 February 2020 BASF and Fabbri Group develop certified compostable cling film for fresh-food packaging.BASF and Fabbri Group have developed a sustainable solution for cling film used in fresh-food packaging: Based on BASF’s certified compostable ecovio®, Fabbri Group produces the highly transparent stretch film Nature Fresh. Meat, seafood as well as fruit and vegetables can be wrapped manually or with automatic packaging equipment.

Regulatory Insights:
The FDA approved Anhyrous trimethylglycine (also known as by the brand name Cystadane for the treatment of homocystinuria, a disease caused by abnormally high homocysteine levels at birth. TMG is also used as the hydrochloride salt. Betaine hydrochloride was once permitted in over-the-counter (OTC) drugs as a gastric aid in the United States. US Code of Federal Regulations, Title 21, Section 310.540, which became effective on November 10, 1993, banned betaine hydrochloride from being used in OTC products due to insufficient evidence to classify it as generally recognized as safe and effective.

Market Drivers
  • Highly Demanded As Supplement
  • Growing Use For Treatment Of Depression, Schizophrenia, Demyelination Diseases, Liver Disease, Dementia, Arthritis, And Other Conditions

Market Trend
  • Growing Demand Of TMG Containing Fertilizer

Restraints
  • Major Medical Symptoms Like Stomach Upset, And Diarrhea

Opportunities
Growing Demand In Cosmetic And Aquaculture and Highly Demanded In Nutraceutical
Challenges
Harmful For Consumer With High Cholesterol and Hazardous For Pregnant Women

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Biosynthesis
  • Chemical Synthesis
  • PCR technique
By Application
  • Dietary Supplement
  • Agriculture and Aquaculture
  • Clinical trials
  • Cosmetics
  • Detergents
By Availabilty
  • Liquid
  • Powder
  • Capsules

By End User
  • Pharmaceutical and Neutraceuticals
  • Fertilizer Companies
  • Chemical industries

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Highly Demanded As Supplement
      • 3.2.2. Growing Use For Treatment Of Depression, Schizophrenia, Demyelination Diseases, Liver Disease, Dementia, Arthritis, And Other Conditions
    • 3.3. Market Challenges
      • 3.3.1. Harmful For Consumer With High Cholesterol
      • 3.3.2. Hazardous For Pregnant Women
    • 3.4. Market Trends
      • 3.4.1. Growing Demand Of TMG Containing Fertilizer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Trimethylglycine, by Type, Application, Availabilty, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Trimethylglycine (Value)
      • 5.2.1. Global Trimethylglycine by: Type (Value)
        • 5.2.1.1. Biosynthesis
        • 5.2.1.2. Chemical Synthesis
        • 5.2.1.3. PCR technique
      • 5.2.2. Global Trimethylglycine by: Application (Value)
        • 5.2.2.1. Dietary Supplement
        • 5.2.2.2. Agriculture and Aquaculture
        • 5.2.2.3. Clinical trials
        • 5.2.2.4. Cosmetics
        • 5.2.2.5. Detergents
      • 5.2.3. Global Trimethylglycine by: Availabilty (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Powder
        • 5.2.3.3. Capsules
      • 5.2.4. Global Trimethylglycine by: End User (Value)
        • 5.2.4.1. Pharmaceutical and Neutraceuticals
        • 5.2.4.2. Fertilizer Companies
        • 5.2.4.3. Chemical industries
      • 5.2.5. Global Trimethylglycine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Trimethylglycine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. American Crystal Sugar (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Associated British Foods (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BASF (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DuPont (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cambridge Isotope Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Compound Solutions (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Creative Compounds (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nutreco N.V. (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Amino GMBH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kao Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Trimethylglycine Sale, by Type, Application, Availabilty, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Trimethylglycine (Value)
      • 7.2.1. Global Trimethylglycine by: Type (Value)
        • 7.2.1.1. Biosynthesis
        • 7.2.1.2. Chemical Synthesis
        • 7.2.1.3. PCR technique
      • 7.2.2. Global Trimethylglycine by: Application (Value)
        • 7.2.2.1. Dietary Supplement
        • 7.2.2.2. Agriculture and Aquaculture
        • 7.2.2.3. Clinical trials
        • 7.2.2.4. Cosmetics
        • 7.2.2.5. Detergents
      • 7.2.3. Global Trimethylglycine by: Availabilty (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Powder
        • 7.2.3.3. Capsules
      • 7.2.4. Global Trimethylglycine by: End User (Value)
        • 7.2.4.1. Pharmaceutical and Neutraceuticals
        • 7.2.4.2. Fertilizer Companies
        • 7.2.4.3. Chemical industries
      • 7.2.5. Global Trimethylglycine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Trimethylglycine: by Type(USD Million)
  • Table 2. Trimethylglycine Biosynthesis , by Region USD Million (2013-2018)
  • Table 3. Trimethylglycine Chemical Synthesis , by Region USD Million (2013-2018)
  • Table 4. Trimethylglycine PCR technique , by Region USD Million (2013-2018)
  • Table 5. Trimethylglycine: by Application(USD Million)
  • Table 6. Trimethylglycine Dietary Supplement , by Region USD Million (2013-2018)
  • Table 7. Trimethylglycine Agriculture and Aquaculture , by Region USD Million (2013-2018)
  • Table 8. Trimethylglycine Clinical trials , by Region USD Million (2013-2018)
  • Table 9. Trimethylglycine Cosmetics , by Region USD Million (2013-2018)
  • Table 10. Trimethylglycine Detergents , by Region USD Million (2013-2018)
  • Table 11. Trimethylglycine: by Availabilty(USD Million)
  • Table 12. Trimethylglycine Liquid , by Region USD Million (2013-2018)
  • Table 13. Trimethylglycine Powder , by Region USD Million (2013-2018)
  • Table 14. Trimethylglycine Capsules , by Region USD Million (2013-2018)
  • Table 15. Trimethylglycine: by End User(USD Million)
  • Table 16. Trimethylglycine Pharmaceutical and Neutraceuticals , by Region USD Million (2013-2018)
  • Table 17. Trimethylglycine Fertilizer Companies , by Region USD Million (2013-2018)
  • Table 18. Trimethylglycine Chemical industries , by Region USD Million (2013-2018)
  • Table 19. South America Trimethylglycine, by Country USD Million (2013-2018)
  • Table 20. South America Trimethylglycine, by Type USD Million (2013-2018)
  • Table 21. South America Trimethylglycine, by Application USD Million (2013-2018)
  • Table 22. South America Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 23. South America Trimethylglycine, by End User USD Million (2013-2018)
  • Table 24. Brazil Trimethylglycine, by Type USD Million (2013-2018)
  • Table 25. Brazil Trimethylglycine, by Application USD Million (2013-2018)
  • Table 26. Brazil Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 27. Brazil Trimethylglycine, by End User USD Million (2013-2018)
  • Table 28. Argentina Trimethylglycine, by Type USD Million (2013-2018)
  • Table 29. Argentina Trimethylglycine, by Application USD Million (2013-2018)
  • Table 30. Argentina Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 31. Argentina Trimethylglycine, by End User USD Million (2013-2018)
  • Table 32. Rest of South America Trimethylglycine, by Type USD Million (2013-2018)
  • Table 33. Rest of South America Trimethylglycine, by Application USD Million (2013-2018)
  • Table 34. Rest of South America Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 35. Rest of South America Trimethylglycine, by End User USD Million (2013-2018)
  • Table 36. Asia Pacific Trimethylglycine, by Country USD Million (2013-2018)
  • Table 37. Asia Pacific Trimethylglycine, by Type USD Million (2013-2018)
  • Table 38. Asia Pacific Trimethylglycine, by Application USD Million (2013-2018)
  • Table 39. Asia Pacific Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 40. Asia Pacific Trimethylglycine, by End User USD Million (2013-2018)
  • Table 41. China Trimethylglycine, by Type USD Million (2013-2018)
  • Table 42. China Trimethylglycine, by Application USD Million (2013-2018)
  • Table 43. China Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 44. China Trimethylglycine, by End User USD Million (2013-2018)
  • Table 45. Japan Trimethylglycine, by Type USD Million (2013-2018)
  • Table 46. Japan Trimethylglycine, by Application USD Million (2013-2018)
  • Table 47. Japan Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 48. Japan Trimethylglycine, by End User USD Million (2013-2018)
  • Table 49. India Trimethylglycine, by Type USD Million (2013-2018)
  • Table 50. India Trimethylglycine, by Application USD Million (2013-2018)
  • Table 51. India Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 52. India Trimethylglycine, by End User USD Million (2013-2018)
  • Table 53. South Korea Trimethylglycine, by Type USD Million (2013-2018)
  • Table 54. South Korea Trimethylglycine, by Application USD Million (2013-2018)
  • Table 55. South Korea Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 56. South Korea Trimethylglycine, by End User USD Million (2013-2018)
  • Table 57. Taiwan Trimethylglycine, by Type USD Million (2013-2018)
  • Table 58. Taiwan Trimethylglycine, by Application USD Million (2013-2018)
  • Table 59. Taiwan Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 60. Taiwan Trimethylglycine, by End User USD Million (2013-2018)
  • Table 61. Australia Trimethylglycine, by Type USD Million (2013-2018)
  • Table 62. Australia Trimethylglycine, by Application USD Million (2013-2018)
  • Table 63. Australia Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 64. Australia Trimethylglycine, by End User USD Million (2013-2018)
  • Table 65. Rest of Asia-Pacific Trimethylglycine, by Type USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Trimethylglycine, by Application USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Trimethylglycine, by End User USD Million (2013-2018)
  • Table 69. Europe Trimethylglycine, by Country USD Million (2013-2018)
  • Table 70. Europe Trimethylglycine, by Type USD Million (2013-2018)
  • Table 71. Europe Trimethylglycine, by Application USD Million (2013-2018)
  • Table 72. Europe Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 73. Europe Trimethylglycine, by End User USD Million (2013-2018)
  • Table 74. Germany Trimethylglycine, by Type USD Million (2013-2018)
  • Table 75. Germany Trimethylglycine, by Application USD Million (2013-2018)
  • Table 76. Germany Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 77. Germany Trimethylglycine, by End User USD Million (2013-2018)
  • Table 78. France Trimethylglycine, by Type USD Million (2013-2018)
  • Table 79. France Trimethylglycine, by Application USD Million (2013-2018)
  • Table 80. France Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 81. France Trimethylglycine, by End User USD Million (2013-2018)
  • Table 82. Italy Trimethylglycine, by Type USD Million (2013-2018)
  • Table 83. Italy Trimethylglycine, by Application USD Million (2013-2018)
  • Table 84. Italy Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 85. Italy Trimethylglycine, by End User USD Million (2013-2018)
  • Table 86. United Kingdom Trimethylglycine, by Type USD Million (2013-2018)
  • Table 87. United Kingdom Trimethylglycine, by Application USD Million (2013-2018)
  • Table 88. United Kingdom Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 89. United Kingdom Trimethylglycine, by End User USD Million (2013-2018)
  • Table 90. Netherlands Trimethylglycine, by Type USD Million (2013-2018)
  • Table 91. Netherlands Trimethylglycine, by Application USD Million (2013-2018)
  • Table 92. Netherlands Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 93. Netherlands Trimethylglycine, by End User USD Million (2013-2018)
  • Table 94. Rest of Europe Trimethylglycine, by Type USD Million (2013-2018)
  • Table 95. Rest of Europe Trimethylglycine, by Application USD Million (2013-2018)
  • Table 96. Rest of Europe Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 97. Rest of Europe Trimethylglycine, by End User USD Million (2013-2018)
  • Table 98. MEA Trimethylglycine, by Country USD Million (2013-2018)
  • Table 99. MEA Trimethylglycine, by Type USD Million (2013-2018)
  • Table 100. MEA Trimethylglycine, by Application USD Million (2013-2018)
  • Table 101. MEA Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 102. MEA Trimethylglycine, by End User USD Million (2013-2018)
  • Table 103. Middle East Trimethylglycine, by Type USD Million (2013-2018)
  • Table 104. Middle East Trimethylglycine, by Application USD Million (2013-2018)
  • Table 105. Middle East Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 106. Middle East Trimethylglycine, by End User USD Million (2013-2018)
  • Table 107. Africa Trimethylglycine, by Type USD Million (2013-2018)
  • Table 108. Africa Trimethylglycine, by Application USD Million (2013-2018)
  • Table 109. Africa Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 110. Africa Trimethylglycine, by End User USD Million (2013-2018)
  • Table 111. North America Trimethylglycine, by Country USD Million (2013-2018)
  • Table 112. North America Trimethylglycine, by Type USD Million (2013-2018)
  • Table 113. North America Trimethylglycine, by Application USD Million (2013-2018)
  • Table 114. North America Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 115. North America Trimethylglycine, by End User USD Million (2013-2018)
  • Table 116. United States Trimethylglycine, by Type USD Million (2013-2018)
  • Table 117. United States Trimethylglycine, by Application USD Million (2013-2018)
  • Table 118. United States Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 119. United States Trimethylglycine, by End User USD Million (2013-2018)
  • Table 120. Canada Trimethylglycine, by Type USD Million (2013-2018)
  • Table 121. Canada Trimethylglycine, by Application USD Million (2013-2018)
  • Table 122. Canada Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 123. Canada Trimethylglycine, by End User USD Million (2013-2018)
  • Table 124. Mexico Trimethylglycine, by Type USD Million (2013-2018)
  • Table 125. Mexico Trimethylglycine, by Application USD Million (2013-2018)
  • Table 126. Mexico Trimethylglycine, by Availabilty USD Million (2013-2018)
  • Table 127. Mexico Trimethylglycine, by End User USD Million (2013-2018)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Trimethylglycine: by Type(USD Million)
  • Table 139. Trimethylglycine Biosynthesis , by Region USD Million (2019-2024)
  • Table 140. Trimethylglycine Chemical Synthesis , by Region USD Million (2019-2024)
  • Table 141. Trimethylglycine PCR technique , by Region USD Million (2019-2024)
  • Table 142. Trimethylglycine: by Application(USD Million)
  • Table 143. Trimethylglycine Dietary Supplement , by Region USD Million (2019-2024)
  • Table 144. Trimethylglycine Agriculture and Aquaculture , by Region USD Million (2019-2024)
  • Table 145. Trimethylglycine Clinical trials , by Region USD Million (2019-2024)
  • Table 146. Trimethylglycine Cosmetics , by Region USD Million (2019-2024)
  • Table 147. Trimethylglycine Detergents , by Region USD Million (2019-2024)
  • Table 148. Trimethylglycine: by Availabilty(USD Million)
  • Table 149. Trimethylglycine Liquid , by Region USD Million (2019-2024)
  • Table 150. Trimethylglycine Powder , by Region USD Million (2019-2024)
  • Table 151. Trimethylglycine Capsules , by Region USD Million (2019-2024)
  • Table 152. Trimethylglycine: by End User(USD Million)
  • Table 153. Trimethylglycine Pharmaceutical and Neutraceuticals , by Region USD Million (2019-2024)
  • Table 154. Trimethylglycine Fertilizer Companies , by Region USD Million (2019-2024)
  • Table 155. Trimethylglycine Chemical industries , by Region USD Million (2019-2024)
  • Table 156. South America Trimethylglycine, by Country USD Million (2019-2024)
  • Table 157. South America Trimethylglycine, by Type USD Million (2019-2024)
  • Table 158. South America Trimethylglycine, by Application USD Million (2019-2024)
  • Table 159. South America Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 160. South America Trimethylglycine, by End User USD Million (2019-2024)
  • Table 161. Brazil Trimethylglycine, by Type USD Million (2019-2024)
  • Table 162. Brazil Trimethylglycine, by Application USD Million (2019-2024)
  • Table 163. Brazil Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 164. Brazil Trimethylglycine, by End User USD Million (2019-2024)
  • Table 165. Argentina Trimethylglycine, by Type USD Million (2019-2024)
  • Table 166. Argentina Trimethylglycine, by Application USD Million (2019-2024)
  • Table 167. Argentina Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 168. Argentina Trimethylglycine, by End User USD Million (2019-2024)
  • Table 169. Rest of South America Trimethylglycine, by Type USD Million (2019-2024)
  • Table 170. Rest of South America Trimethylglycine, by Application USD Million (2019-2024)
  • Table 171. Rest of South America Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 172. Rest of South America Trimethylglycine, by End User USD Million (2019-2024)
  • Table 173. Asia Pacific Trimethylglycine, by Country USD Million (2019-2024)
  • Table 174. Asia Pacific Trimethylglycine, by Type USD Million (2019-2024)
  • Table 175. Asia Pacific Trimethylglycine, by Application USD Million (2019-2024)
  • Table 176. Asia Pacific Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 177. Asia Pacific Trimethylglycine, by End User USD Million (2019-2024)
  • Table 178. China Trimethylglycine, by Type USD Million (2019-2024)
  • Table 179. China Trimethylglycine, by Application USD Million (2019-2024)
  • Table 180. China Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 181. China Trimethylglycine, by End User USD Million (2019-2024)
  • Table 182. Japan Trimethylglycine, by Type USD Million (2019-2024)
  • Table 183. Japan Trimethylglycine, by Application USD Million (2019-2024)
  • Table 184. Japan Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 185. Japan Trimethylglycine, by End User USD Million (2019-2024)
  • Table 186. India Trimethylglycine, by Type USD Million (2019-2024)
  • Table 187. India Trimethylglycine, by Application USD Million (2019-2024)
  • Table 188. India Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 189. India Trimethylglycine, by End User USD Million (2019-2024)
  • Table 190. South Korea Trimethylglycine, by Type USD Million (2019-2024)
  • Table 191. South Korea Trimethylglycine, by Application USD Million (2019-2024)
  • Table 192. South Korea Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 193. South Korea Trimethylglycine, by End User USD Million (2019-2024)
  • Table 194. Taiwan Trimethylglycine, by Type USD Million (2019-2024)
  • Table 195. Taiwan Trimethylglycine, by Application USD Million (2019-2024)
  • Table 196. Taiwan Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 197. Taiwan Trimethylglycine, by End User USD Million (2019-2024)
  • Table 198. Australia Trimethylglycine, by Type USD Million (2019-2024)
  • Table 199. Australia Trimethylglycine, by Application USD Million (2019-2024)
  • Table 200. Australia Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 201. Australia Trimethylglycine, by End User USD Million (2019-2024)
  • Table 202. Rest of Asia-Pacific Trimethylglycine, by Type USD Million (2019-2024)
  • Table 203. Rest of Asia-Pacific Trimethylglycine, by Application USD Million (2019-2024)
  • Table 204. Rest of Asia-Pacific Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 205. Rest of Asia-Pacific Trimethylglycine, by End User USD Million (2019-2024)
  • Table 206. Europe Trimethylglycine, by Country USD Million (2019-2024)
  • Table 207. Europe Trimethylglycine, by Type USD Million (2019-2024)
  • Table 208. Europe Trimethylglycine, by Application USD Million (2019-2024)
  • Table 209. Europe Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 210. Europe Trimethylglycine, by End User USD Million (2019-2024)
  • Table 211. Germany Trimethylglycine, by Type USD Million (2019-2024)
  • Table 212. Germany Trimethylglycine, by Application USD Million (2019-2024)
  • Table 213. Germany Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 214. Germany Trimethylglycine, by End User USD Million (2019-2024)
  • Table 215. France Trimethylglycine, by Type USD Million (2019-2024)
  • Table 216. France Trimethylglycine, by Application USD Million (2019-2024)
  • Table 217. France Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 218. France Trimethylglycine, by End User USD Million (2019-2024)
  • Table 219. Italy Trimethylglycine, by Type USD Million (2019-2024)
  • Table 220. Italy Trimethylglycine, by Application USD Million (2019-2024)
  • Table 221. Italy Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 222. Italy Trimethylglycine, by End User USD Million (2019-2024)
  • Table 223. United Kingdom Trimethylglycine, by Type USD Million (2019-2024)
  • Table 224. United Kingdom Trimethylglycine, by Application USD Million (2019-2024)
  • Table 225. United Kingdom Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 226. United Kingdom Trimethylglycine, by End User USD Million (2019-2024)
  • Table 227. Netherlands Trimethylglycine, by Type USD Million (2019-2024)
  • Table 228. Netherlands Trimethylglycine, by Application USD Million (2019-2024)
  • Table 229. Netherlands Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 230. Netherlands Trimethylglycine, by End User USD Million (2019-2024)
  • Table 231. Rest of Europe Trimethylglycine, by Type USD Million (2019-2024)
  • Table 232. Rest of Europe Trimethylglycine, by Application USD Million (2019-2024)
  • Table 233. Rest of Europe Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 234. Rest of Europe Trimethylglycine, by End User USD Million (2019-2024)
  • Table 235. MEA Trimethylglycine, by Country USD Million (2019-2024)
  • Table 236. MEA Trimethylglycine, by Type USD Million (2019-2024)
  • Table 237. MEA Trimethylglycine, by Application USD Million (2019-2024)
  • Table 238. MEA Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 239. MEA Trimethylglycine, by End User USD Million (2019-2024)
  • Table 240. Middle East Trimethylglycine, by Type USD Million (2019-2024)
  • Table 241. Middle East Trimethylglycine, by Application USD Million (2019-2024)
  • Table 242. Middle East Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 243. Middle East Trimethylglycine, by End User USD Million (2019-2024)
  • Table 244. Africa Trimethylglycine, by Type USD Million (2019-2024)
  • Table 245. Africa Trimethylglycine, by Application USD Million (2019-2024)
  • Table 246. Africa Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 247. Africa Trimethylglycine, by End User USD Million (2019-2024)
  • Table 248. North America Trimethylglycine, by Country USD Million (2019-2024)
  • Table 249. North America Trimethylglycine, by Type USD Million (2019-2024)
  • Table 250. North America Trimethylglycine, by Application USD Million (2019-2024)
  • Table 251. North America Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 252. North America Trimethylglycine, by End User USD Million (2019-2024)
  • Table 253. United States Trimethylglycine, by Type USD Million (2019-2024)
  • Table 254. United States Trimethylglycine, by Application USD Million (2019-2024)
  • Table 255. United States Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 256. United States Trimethylglycine, by End User USD Million (2019-2024)
  • Table 257. Canada Trimethylglycine, by Type USD Million (2019-2024)
  • Table 258. Canada Trimethylglycine, by Application USD Million (2019-2024)
  • Table 259. Canada Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 260. Canada Trimethylglycine, by End User USD Million (2019-2024)
  • Table 261. Mexico Trimethylglycine, by Type USD Million (2019-2024)
  • Table 262. Mexico Trimethylglycine, by Application USD Million (2019-2024)
  • Table 263. Mexico Trimethylglycine, by Availabilty USD Million (2019-2024)
  • Table 264. Mexico Trimethylglycine, by End User USD Million (2019-2024)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Trimethylglycine: by Type USD Million (2013-2018)
  • Figure 5. Global Trimethylglycine: by Application USD Million (2013-2018)
  • Figure 6. Global Trimethylglycine: by Availabilty USD Million (2013-2018)
  • Figure 7. Global Trimethylglycine: by End User USD Million (2013-2018)
  • Figure 8. South America Trimethylglycine Share (%), by Country
  • Figure 9. Asia Pacific Trimethylglycine Share (%), by Country
  • Figure 10. Europe Trimethylglycine Share (%), by Country
  • Figure 11. MEA Trimethylglycine Share (%), by Country
  • Figure 12. North America Trimethylglycine Share (%), by Country
  • Figure 13. Global Trimethylglycine share by Players 2018 (%)
  • Figure 14. Global Trimethylglycine share by Players (Top 3) 2018(%)
  • Figure 15. Global Trimethylglycine share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. American Crystal Sugar (United States) Revenue, Net Income and Gross profit
  • Figure 18. American Crystal Sugar (United States) Revenue: by Geography 2018
  • Figure 19. Associated British Foods (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Associated British Foods (United Kingdom) Revenue: by Geography 2018
  • Figure 21. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 22. BASF (Germany) Revenue: by Geography 2018
  • Figure 23. DuPont (United States) Revenue, Net Income and Gross profit
  • Figure 24. DuPont (United States) Revenue: by Geography 2018
  • Figure 25. Cambridge Isotope Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cambridge Isotope Laboratories (United States) Revenue: by Geography 2018
  • Figure 27. Compound Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 28. Compound Solutions (United States) Revenue: by Geography 2018
  • Figure 29. Creative Compounds (United States) Revenue, Net Income and Gross profit
  • Figure 30. Creative Compounds (United States) Revenue: by Geography 2018
  • Figure 31. Nutreco N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Nutreco N.V. (Netherlands) Revenue: by Geography 2018
  • Figure 33. Amino GMBH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Amino GMBH (Germany) Revenue: by Geography 2018
  • Figure 35. Kao Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Kao Corporation (Japan) Revenue: by Geography 2018
  • Figure 37. Global Trimethylglycine: by Type USD Million (2019-2024)
  • Figure 38. Global Trimethylglycine: by Application USD Million (2019-2024)
  • Figure 39. Global Trimethylglycine: by Availabilty USD Million (2019-2024)
  • Figure 40. Global Trimethylglycine: by End User USD Million (2019-2024)
  • Figure 41. South America Trimethylglycine Share (%), by Country
  • Figure 42. Asia Pacific Trimethylglycine Share (%), by Country
  • Figure 43. Europe Trimethylglycine Share (%), by Country
  • Figure 44. MEA Trimethylglycine Share (%), by Country
  • Figure 45. North America Trimethylglycine Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • American Crystal Sugar (United States)
  • Associated British Foods (United Kingdom)
  • BASF (Germany)
  • DuPont (United States)
  • Cambridge Isotope Laboratories (United States)
  • Compound Solutions (United States)
  • Creative Compounds (United States)
  • Nutreco N.V. (Netherlands)
  • Amino GMBH (Germany)
  • Kao Corporation (Japan)
Additional players considered in the study are as follows:
NutriJa Life sciences (India) , Jarrow formulas (United States) , The Life Extension (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation